Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
March 30— The final set of bills to culminate a yearlong Senate effort to spur new medical treatments has been posted ahead of the Senate health panel's April 6 markup.
In a markup notice published March 30, the Senate Health, Education, Labor and Pensions Committee posted five bills on issues ranging from antibiotics, the workforce at the NIH and FDA and precision medicine to the promotion of biomedical research.
The April 6 markup is expected to be the final of three sessions held by the HELP Committee on an effort to accelerate the development of new drugs and devices. As the companion effort to the House-passed 21st Century Cures bill (H.R. 6), HELP Chairman Lamar Alexander (R-Tenn.) has characterized the legislative initiative as “the most important bill signed into law this year,” if it's enacted.
A Senate aide confirmed to Bloomberg BNA that this is the final set of bills for the April 6 agenda:
The workforce bill (S. 2700), which is designed to make it easier to recruit top scientists to work at the National Institutes of Health and the Food and Drug Administration, had already been part of the April 6 agenda .
The antibiotics bill, which is known as the PATH Act, would permit the FDA to accelerate an antibacterial drug's approval for an identifiable, limited patient population if the drug treats a serious or life-threatening condition and addresses an unmet need .
The precision medicine bill would support the White House's ongoing Precision Medicine Initiative to advance an emerging model of health-care delivery that targets treatments to patient subgroups identified by their genetic makeup .
There are no bill numbers or text for the strategic plan or promoting biomedical research bills. However, the NIH released its first-ever agencywide strategic plan this past December that set goals to make significant strides in flu and HIV vaccines, cancer survival rates and diabetes .
HELP so far has approved a total of 14 bills as part of its medical innovation agenda. The first seven bills moved forward during a markup held in February and another seven in March .
However, the committee hasn't resolved the main sticking point of how to pay for these programs. HELP Democrats, particularly ranking member Sen. Patty Murray (D-Wash.) and Sen. Elizabeth Warren (D-Mass.), have made it clear they won't support the medical innovation legislative package without mandatory funding for the NIH and the FDA. Republicans are more hesitant to use a mandatory funding stream, but Alexander said he's open to a short-term “surge fund” to pay for specific projects such as precision medicine. Alexander said he wants to work out the funding portion on the Senate floor as a separate but related legislative effort.
To contact the reporter on this story: Jeannie Baumann in Washington at email@example.com
To contact the editor responsible for this story: Janey Cohen at firstname.lastname@example.org
More information on the April 6 markup is available at http://1.usa.gov/1MTvNsO.
The workforce bill is at https://www.congress.gov/bill/114th-congress/senate-bill/2700; the precision medicine bill is at https://www.congress.gov/bill/114th-congress/senate-bill/2713; and the PATH Act is at https://www.congress.gov/bill/114th-congress/senate-bill/185.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)